PATENT CLAIM ANALYSIS

Application Number: 15911781
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "456000"]

Abstract:
Disclosed are methods comprising administering to a mammal suffering from, or at risk of suffering from, a clock-controlled disorder, such as metabolic syndrome or a constituent condition thereof, a composition comprising at least one polymethoxylated flavone. Disclosed are methods comprising administering a composition comprising at least one polymethoxylated flavone to a mammal suffering from or at risk of suffering from a sleep disorder; suffering from aging; and/or suffering from or at risk of suffering from a mood disorder. The polymethoxylated flavone may be nobiletin and/or tangeretin. The composition may also comprise other compounds, such as nicotinamide riboside and/or pterostilbene, and/or other compounds expected to improve one or more symptoms of metabolic syndrome, a sleep disorder, a mood disorder, aging, a cardiovascular disease, an immune disorder, a neurodegenerative disease, and/or a cancer.

Claim (Index 14):
The method of  claim 13 , wherein the composition is in a form selected from the group consisting of liquids, tablets, capsules, caplets, and soluble powders.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 2.63158
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14679846', '13981592', '13413907', '14573638', '14118116']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7847282048203216
- 35 USC 102 Novelty (BERT): 0.504371839139838
- Combined Prediction Score: 0.7566925682522732
- Mean Citation Score: 195.404344
- Max Citation Score: 210.52727
- Similarity Product: 125.43247005030928

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test